Matches in Wikidata for { <http://www.wikidata.org/entity/Q92865802> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q92865802 description "article scientifique publié en 2019" @default.
- Q92865802 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q92865802 description "scientific article published on 04 April 2019" @default.
- Q92865802 description "wetenschappelijk artikel" @default.
- Q92865802 description "наукова стаття, опублікована 4 квітня 2019" @default.
- Q92865802 name "Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models" @default.
- Q92865802 name "Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models" @default.
- Q92865802 type Item @default.
- Q92865802 label "Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models" @default.
- Q92865802 label "Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models" @default.
- Q92865802 prefLabel "Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models" @default.
- Q92865802 prefLabel "Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models" @default.
- Q92865802 P1433 Q92865802-CE770E90-F3F7-457A-AE05-A32BA854CA2F @default.
- Q92865802 P1476 Q92865802-65AC36A9-B9F9-4C6A-B9A1-B539B3763C0B @default.
- Q92865802 P2093 Q92865802-1DCF52BB-D414-44C8-AEAF-D1AA4E9132E0 @default.
- Q92865802 P2093 Q92865802-5022E04F-2BFD-4A4F-9B9D-A3C5F03E3AEE @default.
- Q92865802 P2093 Q92865802-5E4CC82D-7C9D-4BD4-9871-D702403F24D7 @default.
- Q92865802 P2093 Q92865802-7FE05558-2ECF-4609-93EF-84E8EBF2C6B7 @default.
- Q92865802 P2093 Q92865802-9B052C9C-C41C-4A50-9862-2113254C35C4 @default.
- Q92865802 P2093 Q92865802-A468D426-1F29-42E2-B587-9840887C2558 @default.
- Q92865802 P2093 Q92865802-C0A06AC8-3D73-4845-9DF1-EBD6682498CB @default.
- Q92865802 P304 Q92865802-AF950FCF-A200-4470-BF95-831615C8567E @default.
- Q92865802 P31 Q92865802-AD5C98CE-08E6-4784-BD09-AF484152E676 @default.
- Q92865802 P356 Q92865802-F3C99E23-9E62-4CEC-82F1-4387E26B86F5 @default.
- Q92865802 P407 Q92865802-8535F548-AD6A-49F3-AB27-CA46E9F93922 @default.
- Q92865802 P433 Q92865802-FD4F9011-9083-4A5C-8B26-072175D6D1B7 @default.
- Q92865802 P478 Q92865802-9C4F5848-3D32-4970-B569-0056F68023FF @default.
- Q92865802 P50 Q92865802-09CC75F6-18A8-4A79-A987-7A309B4B8A22 @default.
- Q92865802 P50 Q92865802-5AEF286B-42ED-4A1D-B8E7-B147ED23D2E9 @default.
- Q92865802 P577 Q92865802-049F1809-A18F-47AD-A57E-AB11A4908A61 @default.
- Q92865802 P698 Q92865802-A41DB94F-C26E-4ADF-9A1C-752129E8A4FF @default.
- Q92865802 P356 S00705-019-04232-X @default.
- Q92865802 P698 30949812 @default.
- Q92865802 P1433 Q2860564 @default.
- Q92865802 P1476 "Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models" @default.
- Q92865802 P2093 "Ahmed Ihab Abdelaziz" @default.
- Q92865802 P2093 "Gamal Esmat" @default.
- Q92865802 P2093 "Mohammad El-Sayed" @default.
- Q92865802 P2093 "Mohammed Tarif Hamza" @default.
- Q92865802 P2093 "Nada El-Ekiaby" @default.
- Q92865802 P2093 "Radwa Yehia Mekky" @default.
- Q92865802 P2093 "Shereen Ahmed El Sobky" @default.
- Q92865802 P304 "1587-1595" @default.
- Q92865802 P31 Q13442814 @default.
- Q92865802 P356 "10.1007/S00705-019-04232-X" @default.
- Q92865802 P407 Q1860 @default.
- Q92865802 P433 "6" @default.
- Q92865802 P478 "164" @default.
- Q92865802 P50 Q88611540 @default.
- Q92865802 P50 Q89537666 @default.
- Q92865802 P577 "2019-04-04T00:00:00Z" @default.
- Q92865802 P698 "30949812" @default.